PTC Therapeutics Insider Trades
NASDAQ: PTCTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 1:03 PM ET
Last 12 months
- Purchases
- 0 · $0
- Sales
- 2 · $132.79K
- Shares bought / sold
- 0 / 2.07K
- Net activity
- Net selling $132,791
PTC Therapeutics insider activity
Over the last 12 months, PTC Therapeutics insiders reported 4 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $132,791 worth of stock, for net insider selling of $132,791. The largest seller was Boulding Mark Elliott, with $132,791 in reported sales.
The most recent filing shows Boulding Mark Elliott (EXEC. VP AND CLO) reporting a transaction in 435 shares at $39.42 on Oct 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PTCT's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PTCT insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 6, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Sale | 435 | $27.91K | Form 4 |
| Oct 6, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Option exercise | 435 | $17.15K | Form 4 |
| Oct 5, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Sale | 1,638 | $104.88K | Form 4 |
| Oct 5, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Option exercise | 1,638 | $64.57K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4